EXDI -- USA Stock  

USD 0.95  0.05  5.00%

EXACTUS INC owns latest Real Value of $0.9009 per share. The recent price of the firm is $0.95. the firm appears to be overvalued. This module computes value of EXACTUS INC from analyzing the firm fundamentals such as Price to Earning of (1.21)X, Shares Owned by Insiders of 35.16% and Return On Asset of (85.64)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we advise to invest in undervalued equities and to sell out overvalued equities since in the future instruments prices and their ongoing real values will draw towards each other.
September 17, 2019
Market Value
Real Value
EXACTUS INC is out of control asset. Calculation of real value of EXACTUS INC is based on 3 months time horizon. Increasing EXACTUS INC time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
EXACTUS INC Valuation Data Drivers
Average Assets    Enterprise Value    Market Capitalization    


EXACTUS INC is rated below average in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 42.7 Billion. EXACTUS INC adds roughly 34.93 Million in market capitalization claiming only tiny portion of equities under Drug Manufacturers - Specialty & Generic industry.
Capitalization  Revenue  Workforce  Total debt  Valuation
Horizon     30 Days    Login   to change
EXACTUS INC is rated # 4 in beta category among related companies. It is rated # 4 in price to sales category among related companies fabricating about  34.58  of Price to Sales per Beta.

Valuation Basics

EXACTUS INC Enterprise Value Fundamentals

Quick Ratio0.43
Enterprise Value To Revenue222.97
Additionally see Investing Opportunities. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com